News

Gyros Protein Technologies becomes distributor of iLite cell-based reporter gene assays for drug development.

Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that last for at least one year.

To help prevent illnesses caused by bacteria in food or water, researchers have developed a new nanosensor to rapidly detect its presence.

New study in Neuron focuses on the role that a lack of the protein "CLOCK" plays in several forms of epilepsy.

A newly identified cancer-causing pathway behind most cases of an aggressive type of leukemia could lead to new targeted treatment approaches.

Using human induced pluripotent stem cells (iPSCs), a Massachusetts General Hospital (MGH) research team has bioengineered functional small intestine segments that, when implanted into rats, were capable of delivering nutrients into the bloodstream.

Researchers at the Max Planck Florida Institute for Neuroscience show that location matters when it comes to brain cells’ gene expression, connections, and innervation area.

Cone snails, whose venom has similarities to lionfish and bee venoms, may hold the key to treating Parkinson's disease and drug addiction.

Miami authorities now have a new tool to find the likely source of heroin, potentially opening new avenues to disrupt the nation’s opioid crisis.

Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy.